Unknown

Dataset Information

0

Negative modulation of ?? GABAA receptors in rats may partially prevent memory impairment induced by MK-801, but not amphetamine- or MK-801-elicited hyperlocomotion.


ABSTRACT: Reportedly, negative modulation of ?5 GABAA receptors may improve cognition in normal and pharmacologically-impaired animals, and such modulation has been proposed as an avenue for treatment of cognitive symptoms in schizophrenia. This study assessed the actions of PWZ-029, administered at doses (2, 5, and 10 mg/kg) at which it reached micromolar concentrations in brain tissue with estimated free concentrations adequate for selective modulation of ?5 GABAA receptors, in three cognitive tasks in male Wistar rats acutely treated with the noncompetitive N-methyl-d-aspartate receptor antagonist, MK-801 (0.1 mg/kg), as well in tests of locomotor activity potentiated by MK-801 (0.2 mg/kg) or amphetamine (0.5 mg/kg). In a hormetic-like manner, only 5 mg/kg PWZ-029 reversed MK-801-induced deficits in novel object recognition test (visual recognition memory), whereas in the Morris water maze, the 2 mg/kg dose of PWZ-029 exerted partial beneficial effects on spatial learning impairment. PWZ-029 did not affect recognition memory de?cits in social novelty discrimination procedure. Motor hyperactivity induced with MK-801 or amphetamine was not preventable by PWZ-029. Our results show that certain MK-801-induced memory deficits can be ameliorated by negative modulation of ?5 GABAA receptors, and point to the need for further elucidation of their translational relevance to cognitive deterioration in schizophrenia.

SUBMITTER: Timic Stamenic T 

PROVIDER: S-EPMC4861997 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Negative modulation of α₅ GABAA receptors in rats may partially prevent memory impairment induced by MK-801, but not amphetamine- or MK-801-elicited hyperlocomotion.

Timić Stamenić Tamara T   Joksimović Srdjan S   Biawat Poonam P   Stanković Tamara T   Marković Bojan B   Cook James M JM   Savić Miroslav M MM  

Journal of psychopharmacology (Oxford, England) 20150623 9


Reportedly, negative modulation of α5 GABAA receptors may improve cognition in normal and pharmacologically-impaired animals, and such modulation has been proposed as an avenue for treatment of cognitive symptoms in schizophrenia. This study assessed the actions of PWZ-029, administered at doses (2, 5, and 10 mg/kg) at which it reached micromolar concentrations in brain tissue with estimated free concentrations adequate for selective modulation of α5 GABAA receptors, in three cognitive tasks in  ...[more]

Similar Datasets

| S-EPMC10818464 | biostudies-literature
| S-EPMC1138764 | biostudies-other
| S-EPMC4291316 | biostudies-literature
| S-EPMC4330513 | biostudies-literature
| S-EPMC3410622 | biostudies-other
| S-EPMC5962351 | biostudies-literature
| S-EPMC6116474 | biostudies-literature
2023-01-09 | GSE220510 | GEO
| S-EPMC4657125 | biostudies-literature
| S-EPMC4776125 | biostudies-literature